Scientific and Medical Equipment House Company (TADAWUL:4014)

TADAWUL:4014 Balance Sheet

Financials in millions SAR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	30.88	20.47	88.06	16.95	54.56	45.32
Cash & Short-Term Investments	30.88	20.47	88.06	16.95	54.56	45.32
Cash Growth	29.01%	-76.75%	419.62%	-68.94%	20.38%	-48.87%
Accounts Receivable	690.32	707.8	609.89	810.42	605.22	712.11
Other Receivables	15.06	5.16	6.99	6.87	12.64	4.7
Receivables	705.37	712.96	616.89	817.29	617.86	716.81
Inventory	57.07	65.85	103.21	105.03	97.68	97.24
Prepaid Expenses	55.18	25.97	27.48	38.03	37.85	38.57
Other Current Assets	-	29.32	34.58	24.83	26.52	43.73
Total Current Assets	848.5	854.57	870.22	1,002	834.47	941.68
Property, Plant & Equipment	37.1	41.24	46.24	62.07	57.24	43.82
Long-Term Investments	12.29	-	-	-	-	-
Other Intangible Assets	1.06	1.24	0.97	2.5	3.69	-
Other Long-Term Assets	34.76	36.35	34.34	37.34	35.63	32.33
Total Assets	933.71	933.4	951.76	1,104	931.03	1,018

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	65.16	47.99	56.25	49.73	68.49	65.11
Accrued Expenses	93.82	60.32	61.21	67.75	73.08	124.41
Short-Term Debt	142.79	170.22	185.14	332.27	177.88	248.01
Current Portion of Long-Term Debt	9.88	1.75	1.55	1.25	0.16	0.5
Current Portion of Leases	5.38	6.98	5.68	9.47	8.23	4.74
Current Income Taxes Payable	14.2	16.59	15.01	15.46	12.16	6.93
Current Unearned Revenue	15.86	38.31	27.08	23.93	27.75	5.61
Other Current Liabilities	1.02	7.68	8.99	9.5	10.75	19.04
Total Current Liabilities	348.12	349.85	360.91	509.35	378.51	474.35
Long-Term Debt	9.88	5.03	6.78	8.33	9.67	7.23
Long-Term Leases	5.67	7.52	9.01	11.52	10.61	5.77
Pension & Post-Retirement Benefits	72.35	70.16	70.08	68.08	63.61	56.8
Total Liabilities	436.02	432.56	446.78	597.28	462.4	544.15

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	300	300	300	300	200	200
Retained Earnings	206.47	208.69	210.61	210.77	270.37	273.46
Comprehensive Income & Other	0.29	-	-	-	-	-
Total Common Equity	506.76	508.69	510.61	510.77	470.37	473.46
Minority Interest	-9.07	-7.84	-5.62	-4	-1.74	0.22
Shareholders' Equity	497.69	500.84	504.99	506.77	468.63	473.68
Total Liabilities & Equity	933.71	933.4	951.76	1,104	931.03	1,018

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	173.6	191.5	208.15	362.83	206.56	266.24
Net Cash (Debt)	-142.73	-171.03	-120.09	-345.88	-152	-220.92
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-4.79	-5.70	-4.00	-11.53	-5.07	-7.36
Filing Date Shares Outstanding	29.72	30	30	30	30	30
Total Common Shares Outstanding	29.72	30	30	30	30	30
Working Capital	500.38	504.72	509.31	492.79	455.95	467.33
Book Value Per Share	17.05	16.96	17.02	17.03	15.68	15.78
Tangible Book Value	505.7	507.44	509.64	508.27	466.68	473.46
Tangible Book Value Per Share	17.02	16.91	16.99	16.94	15.56	15.78
Buildings	-	0.62	0.59	0.59	0.68	0.68
Machinery	-	98.84	98.7	98.2	87.59	76.35
Leasehold Improvements	-	7.53	7.39	9.65	9.56	8.01

Data Source: S&P Global Market Intelligence Last updated: Nov 4, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 7, 2026

Data Sources Report a data error